New-York Tribune from New York, New York on September 15, 1905 · Page 11
SUGU - Patches pour boutons Spotless | ASOS
Illinois classical studies
PDF) Phase 2, randomized, double‐blind, placebo‐controlled, 4‐week study to evaluate the safety and efficacy of OPA‐ 15406 (difamilast), a new topical selective phosphodiesterase type‐4 inhibitor, in Japanese pediatric patients aged 2–14 years